Explore Products
Primary Cells

Human Brain Cancer Peripheral Blood Mononuclear Cells

  • 151
Included Diagnoses: Glioblastoma (Including subtypes), Astrocytoma (Including subtypes), Oligodendroglioma (Including subtypes), Oligoastrocytoma (Including subtypes), Ependyoma (Including subtypes), Meningioma (Including subtypes), Neurilemoma, Ganglioma (Including subtypes), Neurocytoma.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC4348

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Brain Cancer

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Brain Cancer Peripheral Blood Mononuclear Cells are mainly derived from the patient’s peripheral blood. They are represent a heterogeneous cell population, including lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are round or oval. PBMCs are mainly involved in immune surveillance and tumor microenvironment regulation in brain cancer: CD8+ T cells can recognize tumor antigens, NK cells mediate natural killing, and monocytes differentiate into tumor-associated macrophages (TAMs), which may have both tumor-promoting and tumor-suppressive functions.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Brain Cancer Peripheral Blood Mononuclear Cells can be used for immunotherapy research, such as in vitro expansion and functional evaluation of CAR-T cell therapy, or target screening to enhance anti-tumor immune responses. In addition, immunophenotyping of PBMCs (such as PD-1 and CTLA-4 expression levels) can assess the patient’s immunosuppressive status and guide immune checkpoint inhibitor therapy.

Inquiring Human Brain Cancer Peripheral Blood Mononuclear Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button